Paid Clinical Trials in Greensboro, NC
Here are the 6 most popular medical studies in paid studies greensboro
Behavioral Intervention
Pressure Relief Education and Training for Pressure Ulcer
Recruiting1 award
Charlotte, North Carolina
"This trial explores how people with progressive disorders who use power wheelchairs and their caregivers may face challenges in performing pressure relief, which is important for preventing complications. They may struggle to remember to do it
Interview Group for Pancreatic Cancer
Recruiting1 award
Chapel Hill, North Carolina
This trial aims to create a mobile app specifically for Black patients with pancreatic cancer to help them learn more about clinical trials and communicate better with their healthcare team. The goal is to increase participation of Black patients
Popular filter options for paid studies greensboro trials
Phase 3 Clinical Trials
View 93 phase 3 medical studies.
Corticosteroid
Budesonide +1 More for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Oxon Hill, Maryland
This trial will compare the effect of using a combination inhaler (BGF) containing three types of medication versus a different combination inhaler (GFF) in people with COPD and high risk for
GLP-1 Receptor Agonist
Semaglutide +1 More for Type 2 Diabetes
Recruiting2 awardsPhase 3
Greensboro, North Carolina
"This trial will compare the effectiveness and safety of retatrutide and semaglutide in people with Type 2 Diabetes who are not managing their blood sugar well with metformin alone or with
Procedure
Valeda Light Delivery System for Age-Related Macular Degeneration
Recruiting1 awardPhase 2 & 3
Durham, North Carolina
This trial is a continuation of a previous study on the use of photobiomodulation in people with dry age-related macular degeneration. It is open to participants from multiple centers.
Clinical Trials With No Placebo
View 93 medical studies that do not have a placebo group.
Corticosteroid
Budesonide +1 More for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Oxon Hill, Maryland
This trial will compare the effect of using a combination inhaler (BGF) containing three types of medication versus a different combination inhaler (GFF) in people with COPD and high risk for
Checkpoint Inhibitor
Nivolumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Durham, North Carolina
"This trial is testing a combination of chemotherapy and immunotherapy followed by radiotherapy to see how safe and effective it is for patients with advanced lung cancer that cannot be surgically removed."
Volunteer control for Dentatorubral-Pallidoluysian Atrophy
Recruiting1 award5 criteria
Chapel Hill, North Carolina
DRPLA Natural History and Biomarkers Study (DRPLA NHBS) is a prospective observational study that will lay the foundation for clinical trials in DRPLA. The aims of this project are: To characterize the natural history of DRPLA in both juvenile- and adult-onset patients and study different modalities of biomarkers in this condition. To identify genetic factors and biomarkers that could predict disease progression. To provide a platform to support the design and conduct of clinical trials. This study has three arms: Adult Participants: this arm of the study will require participants to be 16 years old or over to participate. Pediatric Participants: this arm of the study will require participants to be under 16 years old to participate. Remote Participants: patients that cannot or do not wish to travel to one of the study sites can participate in this arm of the study, irrespective of their age. Participants will have an annual visit for three years (baseline visit and two follow-up visits, three visits in total). Subjects who complete the whole protocol will be assessed on two consecutive days to reduce patient burden. This project will allow for a better understanding of DRPLA and its course, and therefore allow for future clinical trials on this condition to be more precisely and effectively conducted.
GLP-1 Receptor Agonist
Semaglutide +1 More for Type 2 Diabetes
Recruiting2 awardsPhase 3
Greensboro, North Carolina
"This trial will compare the effectiveness and safety of retatrutide and semaglutide in people with Type 2 Diabetes who are not managing their blood sugar well with metformin alone or with
Infants of women exposed to ruxolitinib cream during pregnancy for Atopic Dermatitis
Recruiting1 award8 criteria
Morrisville, North Carolina
This observational (enrollment into the registry while the pregnancy is ongoing) study is being conducted to compare the frequency of major congenital malformation (MCM)s among infants of women exposed to ruxolitinib cream during pregnancy with infants of women not exposed to ruxolitinib cream during pregnancy.
View More Paid Studies Greensboro Trials
See another 76 medical studies focused on paid studies greensboro.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.